Chemweb Events

Digital Marketing for Pharmaceutical and Medical Devices: Expectations from FDA Sep 4-5 2014
Course: United States [in English]

Overview:
The changing game for drug and device marketing, however, is governed by antiquated and inadequate rules created for traditional print and broadcast advertising by the Food and Drug Administration ("FDA"). How the FDA will deal with such advanced communication technology that can go "viral" and just as quickly disappear is the question that the industry is eager to have answered.

The FDA regulates the promotion of prescription drugs, biologics, medical devices and biotechnology products to ensure that the information is not false or misleading. The FDA has for decades regulated traditional advertising for decades, published various guidance documents for industry and issued many violation letters. If the FDA determines that drug or medical device promotional material is false or misleading or lacking in fair balance as between benefits and risks, companies could be forced to implement costly corrective actions, such as remedial advertising, suffer damage to their reputations and incur monetary fines. Already, the government has collected billions of dollars in fines, forfeitures and disgorgements from drug companies for the alleged marketing of a product for unapproved, or "off-label," uses.

Date, Venue and Time:
Location: Chicago, IL
Date: September 4th and 5th, 2014
Time: 9 am to 6 pm EDT
Venue: Courtyard Chicago O'Hare
Address: 2950 S. River Road Des Plaines Illinois 60018 USA
Price: $1295.00 (Seminar for One Delegate)
Discount: Register now and save $200. (Early Bird)
Until August 15, Early Bird Price: $1,295.00
From August 16 to September 02, Regular Price: $1,495.00

Contact Information:
John Robinson
Toll free: 1800-447-9407
Fax: 302-288-6884
Email: support@globalcompliancepanel.com
Website: https://www.globalcompliancepanel.com
Live Chat - Online Help Desk: http://www.globalcompliancepanel.com/chat/client.php
GlobalCompliancePanel
NetZealous LLC
161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
For More Info on This Seminar Kindly Go through the Below Link: http://bit.ly/Drugs-and-MedicalDevices

Event Location:
Courtyard Chicago O'Hare
2950 S. River Road Des Plaines
Chicago, IL 60611
United States

Organizer:
John Robinson (send an email)
161 Mission Falls Lane
Suite 216
Fremont, CA 94539
United States
Deadlines
Early registration: Tuesday, September 2, 2014
Posters: Tuesday, August 12, 2014
Keynote speakers:

David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. He has been involved in many FDA and other regulatory inspections as well as part of multiple FDA remediation activities involving CIA's Consent Decrees, Seizures and other enforcement actions, including responding to Warning Letters. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, addresses all aspects of postmarketing requirements involving advertising, promotional and labeling claims, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses global regulatory requirements.

Session titles:

Day One
Lecture 1: Required Elements of All Advertising and Promotional Materials for Drugs and Medical Devices
Lecture 2: Promotion, Labelling and Advertising
Lecture 3: Misbranding/Off-Label Information and Issues
Lecture 4: FDA Enforcement Surveillance
Lecture 5: Social Media
Lecture 6: Enforcement Tools
Lecture 7: The FDA has an escalating arsenal of enforcement tools from informal notices to formal administrative notices to civil actions and finally to criminal prosecution.
Lecture 8: Untitled Letter and the Warning Letters
Lecture 9: Seizures

Day Two:
Lecture 10: Injunctions/Consent Decrees
Lecture 11: OIG/DOJ/False Claims Act and Other Acts and OIG Settlements/CIA's
Lecture 12: Physician Payments Sunshine Act
Lecture 13: The federal Anti-Kickback statute presents many potential pitfalls for medical device manufacturers looking to promote their products.
Lecture 14: Disclose risk information in prescription drug and medical device promotion appropriately and effectively to healthcare professionals and consumers
Lecture 15: Company Policies and Procedures
Lecture 16: AdvaMed Code of Ethics on Interactions with HCP's
Lecture 17: Integrating FDA compliance elements into Healthcare Compliance or Corporate Compliance

Registration fees and grants:

Price: $1295.00 (Seminar for One Delegate)
Discount: Register now and save $200. (Early Bird)
Until August 15, Early Bird Price: $1,295.00
From August 16 to September 02, Regular Price: $1,495.00
Want to register by Wire Transfer?
Please call any of our representatives on 1800 447 9407 to help you completed the transfer.

Sponsors:

GlobalCompliancePanel